Comparison between Brilinta vs Plavix
| Parameter | Brilinta | Plavix |
|---|---|---|
| Class | P2Y12 inhibitor | P2Y12 inhibitor |
| Mechanism | Reversible inhibition | Irreversible inhibition |
| Onset | Rapid | Gradual |
| Monitoring | None | None |
| Dosing | BD | OD |
| Half-life | ~7h | ~6h |
| Reversal Agent | None | None |
| Bleeding Risk | Moderate | Moderate |
| Indications | ACS | ACS |
| Renal Use | Caution | Caution |
| Pregnancy Use | Avoid | Avoid |
| Drug Interactions | Moderate | Moderate |
| Adherence Sensitivity | High | Moderate |
| Best Use Case | More potent | Standard therapy |
| Cost | High | Low |
| Monitoring Burden | Low | Low |
| Clinical Flexibility | Moderate | Moderate |
| Real-world Convenience | Moderate | Moderate |
| Overall Verdict | Stronger | Cheaper |
| Food Interactions | None | None |